Dr. Mary and Ron Neal Cancer Center

Medicine & Life Sciences

1. Neoplasms 100%
2. Breast Neoplasms 80%
3. Genes 47%
4. Aryl Hydrocarbon Receptors 40%
5. Therapeutics 39%
6. Survival 35%
7. Radiotherapy 34%
8. Apoptosis 33%
9. Polychlorinated Dibenzodioxins 32%
10. Growth 30%
11. Proteins 29%
12. Lung 29%
13. Liver Transplantation 29%
14. T-Lymphocytes 29%
15. Estrogen Receptors 29%
16. Neoplasm Metastasis 28%
17. Lung Neoplasms 25%
18. Drug Therapy 25%
19. Prostatic Neoplasms 24%
20. Liver 23%
21. Triple Negative Breast Neoplasms 22%
22. Immunotherapy 22%
23. Multiple Myeloma 22%
24. Gene Expression 22%
25. Carcinogenesis 21%
26. Mutation 20%
27. Ligands 20%
28. Pharmaceutical Preparations 20%
29. In Vitro Techniques 19%
30. Cell Line 19%
31. Radiosurgery 18%
32. Pancreatic Neoplasms 18%
33. Transplants 18%
34. Breast 17%
35. Leukemia 16%
36. Recurrence 16%
37. Messenger RNA 16%
38. Estrogens 16%
39. Ovarian Neoplasms 16%
40. DNA 15%
41. Acute Myeloid Leukemia 15%
42. Hepatocellular Carcinoma 15%
43. Sp Transcription Factors 15%
44. Histone Deacetylase Inhibitors 14%
45. Melanoma 14%
46. Non-Small Cell Lung Carcinoma 13%
47. Radiation 13%
48. Benzo(a)pyrene 13%
49. Brain 13%
50. Genetic Therapy 13%
51. MicroRNAs 13%
52. Adenocarcinoma 13%
53. Smooth Muscle Myocytes 12%
54. Phenotype 12%
55. Down-Regulation 12%
56. Neoplastic Stem Cells 12%
57. 3,3'-diindolylmethane 12%
58. heparanase 12%
59. Macrophages 11%
60. Transcriptional Activation 11%
61. Nanoparticles 11%
62. Paclitaxel 11%
63. Phosphotransferases 11%
64. RNA 11%
65. Estradiol 11%
66. Biomarkers 11%
67. Polychlorinated Biphenyls 11%
68. Dendritic Cells 11%
69. Myeloid-Derived Suppressor Cells 11%
70. Myeloid Cells 11%
71. Cell Proliferation 10%
72. Stem Cells 10%
73. Carcinoma 10%
74. Mortality 10%
75. Methane 10%
76. Cytoplasmic and Nuclear Receptors 10%
77. Androgen Receptors 10%
78. Genome 10%
79. Colonic Neoplasms 10%
80. Population 10%
81. Databases 10%
82. Cytochrome P-450 CYP1A1 10%
83. DNA Damage 9%
84. Glioblastoma 9%
85. MCF-7 Cells 9%
86. Immunity 9%
87. Colorectal Neoplasms 9%
88. Tumor Microenvironment 9%
89. Blood Vessels 9%
90. Trastuzumab 9%
91. 6-methyl-1,3,8-trichlorodibenzofuran 9%
92. Confidence Intervals 9%
93. Vascular Smooth Muscle 9%
94. Phosphorylation 9%
95. Cytarabine 9%
96. Kidney 8%
97. Cell Transplantation 8%
98. Prostate 8%
99. Panobinostat 8%
100. DNA Repair 8%